2-Methoxy-E2, also known as 2-methoxyestradiol, is a metabolite of estradiol, a primary estrogen hormone in humans. It is formed through the methylation of estradiol at the 2-position, resulting in the addition of a methoxy (-OCH3) group.
This chemical modification alters the biological activity and metabolic fate of estradiol, giving rise to a compound with distinct properties and functions.
In recent years, researchers have increasingly focused on 2-Methoxy-E2 due to its potential role in various physiological processes and its association with disease states.
As a biomarker, 2-Methoxy-E2 offers insights into estrogen metabolism, oxidative stress regulation, and angiogenesis modulation.
2-Methoxy-E2, also known as 2-methoxyestradiol, is a metabolite derived from estradiol, a primary estrogen hormone.
2-Methoxy-E2 is characterized by the addition of a methoxy (-OCH3) group at the 2-position of the estradiol molecule by the Catechol-O-Methyltransferase (COMT) enzyme. This chemical modification alters the structure and properties of estradiol, resulting in a metabolite with distinct biochemical characteristics.
2-Methoxy-E2 has promising functions as an antineoplastic and antimitotic agent and modulates angiogenesis. This compound has been tested in Phase 1 clinical trials for breast cancer and holds potential for treating inflammatory diseases like rheumatoid arthritis due to its ability to inhibit angiogenesis—the process by which new blood vessels form, which is crucial for tumor growth. [14.]
Over the past decade, 2-methoxy-E2 has been increasingly recognized for its anticancer properties and possible cardiovascular benefits, prompting ongoing research into improving its bioavailability through new formulations.
Estrogens play critical roles in various physiological processes including regulating reproductive function and the menstrual cycle, bone health, cardiovascular function, and cognitive function and mood.
Additionally, estrogen signaling influences lipid metabolism, glucose homeostasis, and immune function.
Estrogen also affects skin elasticity, hair growth, body weight, and fat distribution, while contributing to sexual health by enhancing vaginal wall thickness and lubrication. Additionally, estrogen is crucial for breast development during puberty and preparing for lactation.
Estradiol, a primary form of estrogen, is predominantly synthesized in the ovaries' granulosa cells during the follicular phase of the menstrual cycle, mainly through the conversion of androgens like testosterone via the enzyme aromatase. The enzyme 17-beta-hydroxysteroid dehydrogenase, which converts estrone to estradiol, also participates in estradiol production.
Estradiol is also produced in peripheral tissues such as adipose tissue, adrenal glands, and in the placenta during pregnancy. In men, smaller amounts of estradiol are synthesized in the testes and adrenal glands through the conversion of testosterone.
As the primary active form of estrogen in the human body, estradiol serves numerous vital physiological roles. It stimulates the development and maintenance of female reproductive tissues such as the uterus, fallopian tubes, and vagina, and also promotes the growth and maturation of ovarian follicles.
Estradiol is crucial in regulating the menstrual cycle, influencing both the proliferation and shedding of the endometrial lining.
It supports bone health by inhibiting bone resorption and promoting bone formation, and maintains cardiovascular health by regulating lipid metabolism and vascular function.
Additionally, estradiol affects mood and cognition, with its receptors found in brain regions linked to emotion and memory.
It contributes to the health of skin and hair by promoting collagen production and regulating sebum production. Estradiol also plays a role in the integrity of pelvic floor muscles, thereby supporting urinary tract function and preventing incontinence.
It influences metabolism and body composition, with receptors present in adipose tissue and skeletal muscle, and impacts immune function by modulating inflammatory responses and interacting with immune cells.
Health Risks of Excessive Estradiol Exposure [8.]
Excessive estradiol exposure is considered dangerous due to its stimulating and proliferative nature.
Excessive exposure to estradiol, particularly through hormone replacement therapy (HRT), can lead to several negative health consequences.
These include an increased risk of cardiovascular issues such as edema, hypertension, and thrombophlebitis. It can also lead to serious conditions like retinal thrombosis, cerebrovascular events, coronary artery disease, and venous thromboembolism.
Furthermore, estradiol therapy has been linked to an elevated risk of certain cancers including breast cancer, and endometrial cancer.
Other potential adverse effects include liver issues and a variety of allergic reactions like anaphylaxis and angioedema. Additionally, estradiol can exacerbate conditions like asthma and cause various skin and gastrointestinal issues.
Given these risks, estradiol therapy is contraindicated for women with a history of certain cancers, blood clotting disorders, cardiovascular diseases, and those who are overweight due to higher baseline estrogen levels in adipose tissue.
The actions of estrogens in the body are influenced by the specific structure of each estrogen molecule, the type of estrogen receptor it binds to, and the cell to which the receptor is attached.
Estrogens exert their effects by binding to estrogen receptors, which are part of the nuclear hormone receptor superfamily. These receptors exist mainly in two forms, estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), each encoded by different genes and varying structurally, particularly in their ligand-binding domains.
This difference in structure affects their affinity for various ligands; for instance, some estrogens and phytoestrogens preferentially bind ERβ, whereas others have a higher affinity for ERα.
Once bound to an estrogen, the receptor undergoes a conformational change, allowing it to dissociate from chaperone proteins and move into the nucleus where it binds to DNA at sites known as estrogen-response elements.
This binding can either activate or repress the transcription of target genes depending on the presence of coactivators or corepressors in the complex.
The distribution of estrogen receptors varies across different tissues, which partly explains the tissue-specific effects of estrogen. For example, ERα is predominantly found in reproductive tissues like the endometrium, while ERβ is more common in non-reproductive tissues such as bone and brain.
This selective expression and the unique interaction of estrogens with their receptors underpin the diverse physiological roles of estrogens, from reproductive functions to their roles in bone density and cardiovascular health.
2-Methoxy-E2 has shown promise as an anti-cancer agent and may also benefit patients with rheumatoid arthritis.
2-Methoxy-E2 as an Anti-Cancer Agent [9., 11.]
2-Methoxy-E2 is currently in clinical trials for its antitumor and antiangiogenic properties, which primarily occur through a novel mechanism that disrupts microtubules and modulates HIF-1α protein levels.
This compound inhibits the proliferation of endothelial cells essential for new blood vessel formation—a critical process for tumor growth—and induces apoptosis in these cells.
2-Methoxy-E2 operates by binding to tubulin, preventing microtubule assembly, which leads to mitotic arrest and apoptosis. It also downregulates HIF-1α, a transcription factor vital for responses to low oxygen levels in tumors, thereby reducing VEGF expression and other HIF-1α regulated genes critical for tumor angiogenesis and survival.
The interplay between microtubule disruption and HIF-1α modulation presents a promising therapeutic pathway, distinguishing 2ME2 from other antineoplastic agents that target microtubules.
2-Methoxy-E2 and Rheumatoid Arthritis [15.]
2-Methoxy-E2 has shown promise as a therapeutic agent for rheumatoid arthritis (RA), particularly due to its antiangiogenic and anti-inflammatory properties.
In studies using the collagen antibody-induced arthritis (CAIA) model in mice, 2-Methoxy-E2 demonstrated disease-modifying activity by significantly inhibiting neovascularization associated with pannus formation in the joints.
Treatment with 2-Methoxy-E2 led to a dose-dependent reduction in arthritis severity, characterized by decreased synovial inflammation, pannus formation, cartilage degradation, and bone resorption.
This effect was further supported by a reduction in the expression of inflammatory cytokines (such as IL-1β, TNF-α, IL-6, and IL-17) and angiogenic factors (VEGF and FGF-2) within the joint space.
2-Methoxy-E2 as a Neuroprotective Agent [18., 23.]
Hypoxia-inducible factor 1-α (HIF-1α) is crucial in maintaining cellular homeostasis under cerebral ischemia conditions such as traumatic brain injury. Its inhibition can reduce secondary brain damage by affecting its proteasomal degradation and nuclear translocation.
Animal studies have demonstrated that 2-methoxy-E2 can reduce secondary brain damage 24 hours post-injury by reducing the expression of HIF-1α target genes associated with neuropathology, such as Plasminogen Activator Inhibitor 1 and Tumor Necrosis Factor Alpha. [18., 22.]
Additionally, 2-methoxy-E2 attenuated the expression of the pro-apoptotic protein BNIP3 triggered by TBI. An alternatively spliced variant of HIF-1α, HIF-1α∆Ex14, was significantly upregulated from 6 to 48 hours after TBI, displaying impaired nuclear location and gene transcription activity compared to the full-length HIF-1α, although it did not affect the nuclear translocation of HIF-1β.
The findings from these studies suggest that 2-methoxy-E2's neuroprotective effects may stem from inhibiting a detrimental HIF-1α response.
Urine samples are commonly used for 2-methoxy-E2 testing.
Estrogen metabolites can be excreted in the urine, making it a reliable method for testing estrogen detoxification and comparing ratios of estrogen metabolites. Urine testing specifically assesses phase I estrogen detoxification, and it can also be used to assess phase II methylation detoxification.
Urine collection can be easier and less stressful for patients compared to blood draws, as samples can be collected at home without the need for a clinical setting.
Additionally, urinary levels can reflect longer-term hormone exposure rather than the transient levels often seen in blood, as it reflects detoxification patterns (rather than providing snapshots of levels in the bloodstream).
It is important to consult with the lab company providing testing for 2-methoxy-E2 levels. For reference, one lab provides the following reference range for urine 2-methoxy-E2 levels: [17.]
For cycling women in the luteal phase: 0.012-0.039 ng/mg creatinine/day
Hormones never act alone, and their effects are nuanced. Optimal levels of 2-methoxyestradiol in urine tests vary depending on individual health conditions, gender, and age. The 2-methoxy detoxification pathway is generally considered a preferred estrogen detoxification pathway.
One recommendation is that 60-80% of a woman's circulating estrogen utilize the 2-OH pathway; that 13-30% utilizes the 16-OH pathway; and that the remaining 7.5-11% utilize the 4-OH pathway. [17.]
Health professionals often recommend that women remain within the reference range of 0.012-0.039 ng/mg in urine samples.
However, a professional's recommendation will be affected by many factors including the patient’s overall health, detoxification capacity, personal and family health history, time of life, diet and lifestyle, medications, and other factors.
Regular monitoring through urinary tests is essential to ensure that the metabolite levels are within a safe range, thereby reducing the potential for DNA damage and promoting better hormonal balance and overall health.
In addition to 2-methoxy-E2, several related biomarkers play crucial roles in estrogen metabolism and hormonal balance. Understanding these biomarkers and their interactions can provide a more comprehensive assessment of hormonal health and metabolic status.
Estrone is a weaker estrogen compared to estradiol but is prevalent in postmenopausal women and can be converted back to estradiol.
Testing for estrone is important for understanding the overall estrogenic activity, especially in postmenopausal women who are at increased risk for estrogen-sensitive cancers.
Estradiol (E2), often referred to as the primary estrogen, is the precursor for 2-methoxy-E2 and other estrogen metabolites. It plays essential roles in reproductive health, bone metabolism, and cardiovascular function.
Measuring estradiol levels provides insights into overall estrogen production and ovarian function. In combination with 2-methoxy-E2, estradiol levels can help assess estrogen metabolism and balance.
Estriol is a weak estrogen predominantly produced during pregnancy. Outside of pregnancy, its levels are very low, but it has been suggested to have protective effects against breast cancer.
Testing for estriol, especially in non-pregnant states, might provide additional insights into estrogenic activity and potential protective mechanisms against estrogen-related pathologies.
16α-Hydroxyestrone (16α-OH-E1) is another estrogen metabolite formed through hydroxylation at the 16α position of estrone. Higher levels of 16α-OH-E1 have been associated with increased estrogenic activity and cancer risk, particularly in hormone-sensitive tissues such as the breast and uterus. [4.]
4-OH estrone is another metabolite of estrone with strong estrogenic properties and potential carcinogenic effects.
Specifically, 4-OH estrone is known for its potential to form quinones that can directly damage DNA and generate reactive oxygen species, increasing the risk of mutagenesis.
Measuring 4-OH estrone alongside 16-OH estrone and 2-OH estrone can help assess the overall estrogenic and carcinogenic potential within the body.
It is always essential to work with a qualified healthcare professional in any case of hormone imbalance. The following diet and lifestyle measures have been shown to naturally promote healthy hormone balance:
Dietary Fiber Increase: consuming more fiber helps bind estrogen in the digestive tract, promoting its excretion and reducing reabsorption. [6.]
Interestingly, one study of 240 women also showed a correlation between increased fiber intake and anovulation, possibly due to lower estrogen levels. [6.]
Cruciferous Vegetables: foods like broccoli, cauliflower, and Brussels sprouts contain indole-3-carbinol, which aids in detoxifying excessive estrogen and optimizing hormone balance. [2.]
Regular Exercise: physical activity can help balance hormones by improving metabolism and reducing fat, which is significant since body fat can produce and store estrogen. [20.]
Probiotics and Gut Health: a healthy gut flora supports proper digestion and detoxification processes, including the breakdown, elimination and balance of hormones like estrogen. [12.]
Limit Alcohol and Caffeine: reducing intake of substances that can impair liver function helps ensure the liver effectively processes and removes excess hormones. [5., 19.]
Stress Management: stress may have an impact on estrogen levels and metabolism; techniques such as yoga, meditation, or even simple breathing exercises can reduce cortisol levels and help maintain a healthy hormonal balance. [1.]
Click here to explore testing options and order testing for 2-Methoxy-E2 levels.
[1.] Assad S, Khan HH, Ghazanfar H, Khan ZH, Mansoor S, Rahman MA, Khan GH, Zafar B, Tariq U, Malik SA. Role of Sex Hormone Levels and Psychological Stress in the Pathogenesis of Autoimmune Diseases. Cureus. 2017 Jun 5;9(6):e1315. doi: 10.7759/cureus.1315. PMID: 28690949; PMCID: PMC5498122.
[2.] Auborn KJ, Fan S, Rosen EM, et al. Indole-3-Carbinol Is a Negative Regulator of Estrogen. The Journal of Nutrition. 2003;133(7):2470S2475S. doi:https://doi.org/10.1093/jn/133.7.2470s
[3.] Bukato, K., Kostrzewa, T., Gammazza, A.M. et al. Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers. Cell Commun Signal 22, 205 (2024). https://doi.org/10.1186/s12964-024-01583-0
[4.] Diaz-Ruano AB, Martinez-Alarcon N, Perán M, Benabdellah K, Garcia-Martinez MLÁ, Preda O, Ramirez-Tortosa C, Gonzalez-Hernandez A, Marchal JA, Picon-Ruiz M. Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, EMT and Stemness in ER+ Cancer Cells. Int J Mol Sci. 2023 Jan 7;24(2):1221. doi: 10.3390/ijms24021221. PMID: 36674737; PMCID: PMC9865376.
[5.] Emanuele MA, Wezeman F, Emanuele NV. Alcohol's effects on female reproductive function. Alcohol Res Health. 2002;26(4):274-81. PMID: 12875037; PMCID: PMC6676690.
[6.] Gaskins AJ, Mumford SL, Zhang C, et al. Effect of daily fiber intake on reproductive function: the BioCycle Study. The American Journal of Clinical Nutrition. 2009;90(4):1061-1069. doi:https://doi.org/10.3945/ajcn.2009.27990
[7.] Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and Actions of Estrogens. New England Journal of Medicine. 2002;346(5):340-352. doi:https://doi.org/10.1056/nejmra000471
[8.] Hariri L, Rehman A. Estradiol. [Updated 2023 Jun 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549797/
[9.] https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol. www.cancer.gov. Published 2011. Accessed May 1, 2024. https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-methoxyestradiol
[10.] Li X, Fang L, Li H, Yang X. Urinary estrogen metabolites and breast cancer risk in Chinese population. Endocr Connect. 2021 Dec 14;10(12):1615-1622. doi: 10.1530/EC-21-0226. PMID: 34812737; PMCID: PMC8679875.
[11.] Mabjeesh NJ, Escuin D, LaVallee TM, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. 2003;3(4):363-375. doi:https://doi.org/10.1016/s1535-6108(03)00077-1
[12.] Maeng LY, Beumer A. Never fear, the gut bacteria are here: Estrogen and gut microbiome-brain axis interactions in fear extinction. International Journal of Psychophysiology. 2023;189:66-75. doi:https://doi.org/10.1016/j.ijpsycho.2023.05.350
[13.] Masood DE, Roach EC, Beauregard KG, Khalil RA. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. Curr Drug Metab. 2010 Oct;11(8):693-714. doi: 10.2174/138920010794233477. PMID: 21189141; PMCID: PMC3063102.
[14.] Mueck AO, Seeger H. 2-Methoxyestradiol—Biology and mechanism of action. Steroids. 2010;75(10):625-631. doi:https://doi.org/10.1016/j.steroids.2010.02.016
[15.] Plum SM, Park EJ, Strawn SJ, Moore EG, Sidor CF, Fogler WE. Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis. BMC Musculoskelet Disord. 2009 May 1;10:46. doi: 10.1186/1471-2474-10-46. PMID: 19409094; PMCID: PMC2687416.
[16.] 1.PubChem. 2-Methoxyestradiol. pubchem.ncbi.nlm.nih.gov. https://pubchem.ncbi.nlm.nih.gov/compound/2-Methoxyestradiol
[17.] RUPA Health. 1.Estrogen Metabolites Profile Sample Report.pdf. Google Docs. Accessed May 1, 2024. https://drive.google.com/file/d/1nEwGz74OzsPUDQTwjEnyAkWf-Zo3JZ_0/view
[18.] Schaible EV, Windschügl J, Bobkiewicz W, Kaburov Y, Dangel L, Krämer T, Huang C, Sebastiani A, Luh C, Werner C, Engelhard K, Thal SC, Schäfer MK. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice. J Neurochem. 2014 Jun;129(6):940-54. doi: 10.1111/jnc.12708. Epub 2014 Apr 2. PMID: 24606183.
[19.] Sisti JS, Hankinson SE, Caporaso NE, Gu F, Tamimi RM, Rosner B, Xu X, Ziegler R, Eliassen AH. Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1174-83. doi: 10.1158/1055-9965.EPI-15-0246. Epub 2015 Jun 10. PMID: 26063478; PMCID: PMC4526325.
[20.] Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64. doi: 10.1158/1055-9965.EPI-12-1325. PMID: 23652373; PMCID: PMC3648856.
[21.] The Journal of Clinical Endocrinology & Metabolism. What Does Estrogen Do? The Journal of Clinical Endocrinology & Metabolism. 2014;99(4):31A32A. doi:https://doi.org/10.1210/jc.2014-v99i4-31a
[22.] Wittliff JL, Andres SA. Estrogens II. Elsevier eBooks. Published online January 1, 2014:467-470. doi:https://doi.org/10.1016/b978-0-12-386454-3.01015-0
[23.] Zacharia LC, Eleftheriou C, Gkretsi V. Effects of 2-methoxyestradiol on hydrogen peroxide induced neuronal cell death and tau hyperphosphorylation. Life Sci. 2022 Nov 15;309:121047. doi: 10.1016/j.lfs.2022.121047. Epub 2022 Oct 5. PMID: 36208660.